United Kingdom· GB-APID-45152811000001105
Sunlenca 300mg tablets
A lenacapavir product containing lenacapavir, registered in United Kingdom by Gilead Sciences Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Lenacapavir is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AX31 (lenacapavir), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Lenacapavir · ATC J05AX31
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lenacapavir costs, country by country.
Normalised to the WHO defined daily dose (0.19 g), the median price runs from $0.45 in France to $511.10 in Switzerland — a ×1140 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lenacapavir · price per daily dose (0.19 g)
USD · FX 28 Sept 2026
- CH Switzerland$511.10
- FR France$0.45
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Lenacapavir
- Manufacturer
- Gilead Sciences Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AX31
- ATC class
- Lenacapavir
- Defined daily dose
- 0.19 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5391507147509
- gtin05391507147509
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lenacapavir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaSUNLENCAGILEAD SCIENCES CANADA INC
- United StatesSunlencaGilead Sciences, Inc.
- BelgiumSunlenca 300 mgGilead Sciences Ireland UC
- FinlandSunlencaGilead Sciences Ireland UC
- IrelandSunlenca 300 mg film-coated tabletsGilead Sciences Ireland UC
- IcelandSunlencaGilead Sciences Ireland UC*
- NetherlandsSunlenca 300 mg filmomhulde tablettenGilead Sciences Ireland UC
- PolandSunlencaGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Sunlenca, Yeytuo
- Liechtenstein · Sunlenca, Yeytuo
- Norway · Sunlenca, Yeytuo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/faca5912-736d-4d15-85c6-22adad884648 GET /v1/drugs/faca5912-736d-4d15-85c6-22adad884648?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45152811000001105",
"desc": "Sunlenca 300mg tablets (Gilead Sciences Ltd)",
"form": "Oral tablet",
"vpid": "45160611000001100",
"source": "dmd",
"vtm_id": "45154711000001107",
"strength": "300 mg",
"substance": "Lenacapavir",
"ingredient": "Lenacapavir sodium",
"supplier_code": "2572301000001107"
}See everything about lenacapavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.